Lonza Group has acquired the entire share capital of Micro-Macinazione SA, one of Europe’s leading contract manufacturers providing micronization of active ingredients for the pharmaceutical and fine chemical industries. Micro-Macinazione, which had sales of approx. CHF 20 million in 2016, has 120 employees and is based in Monteggio, Switzerland. Lonza Group, which is listed on the SIX Swiss Exchange, is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets, with more than 50 major manufacturing and R&D facilities and nearly 14,000 full-time employees worldwide.
Bär & Karrer acted as legal advisor to Lonza Group in this transaction. The team included Paolo Bottini (M&A / Tax) and Edoardo Buzzi (M&A).